Catalyst Biosciences Inc
NASDAQ:CBIO
Catalyst Biosciences Inc
Revenue
Catalyst Biosciences Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Catalyst Biosciences Inc
NASDAQ:CBIO
|
Revenue
$794k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$29.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
15%
|
CAGR 10-Years
19%
|
Catalyst Biosciences Inc
Revenue Breakdown
Breakdown by Geography
Catalyst Biosciences Inc
Breakdown by Segments
Catalyst Biosciences Inc
Total Revenue:
794k
USD
|
Collaboration Revenue:
794k
USD
|
See Also
What is Catalyst Biosciences Inc's Revenue?
Revenue
794k
USD
Based on the financial report for Dec 31, 2022, Catalyst Biosciences Inc's Revenue amounts to 794k USD.
What is Catalyst Biosciences Inc's Revenue growth rate?
Revenue CAGR 1Y
-89%
Over the last year, the Revenue growth was -89%.